MENSNasdaqPharmaceutical Preparations
Jyong Biotech Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$1.93+0.09 (+4.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
4 of Jyong Biotech's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Annual report | 20-F | Dec 31, 2025 | May 15, 2026 | SEC EDGAR |
| Current report | 6-K | Feb 6, 2026 | Feb 6, 2026 | SEC EDGAR |
| Current report | 6-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 18, 2025 | Jun 20, 2025 | SEC EDGAR |